惰性T淋巴母细胞增殖性疾病( indolent T lymphoblastic proliferations,iT-LBP)是一种罕见的在胸腺外淋巴组织或器官中出现T淋巴母细胞非克隆性增殖的疾病[1-2],其临床表现、病理学特点以及流式免疫表型与T淋巴母细胞白血病/淋巴瘤(T-lymphoblastic leukemia/lymphoma, T-ALL/LBL)相似,容易导致误诊,因此MICM多种手段...
2. Katsuya, H., et al. Current and emerging therapeutic strategies in adult T-cell leukemia-lymphoma.Int J Hematol, 2023. 3. Tan, B. J. et al. HTLV-1 infection promotes excessive T cell activation and transformation...
[3] WUCART7 1001 Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL). Retrieved January 24, 2024 from https://wugen.com/wp-content/uploads...
The malignancy, arising after the long carrier phase, may be manifested as a lymphoma or acute leukemia, with high white blood cell count and a poor prognosis, usually being fatal within 6–8 months. Smoldering and chronic forms of ATL can convert into an acute course. Approximately 3% of ...
Adult T-cell leukemia-lymphoma (ATL) is a distinct malignancy of CD4+/CD25+/CCR4+/FoxP3+ or- Treg/TH2 cells etiologically associated with human T-cell lymphotropic virus type I (HTLV-1). However, expression of the virus including Tax oncoprotein appears just after in vitro culture, ...
成人T细胞白血病/淋巴瘤(adultT-cell leukemia/lymphoma, ATL)是一种高度侵袭性的T细胞恶性肿瘤,发生于部分长期携带1型人类T淋巴细胞病毒的携带者中。侵袭性亚型的中位生存期为8个月-10个月;采用基于化疗的治疗方法,自ATL首次被描述以来,总生存期在35年内基本保...
T-cell leukemia/lymphoma protein 1A ELISA Kit 价格￥2350￥1250 起批量≥1瓶≥10瓶 最小起订1瓶 供货总量55瓶 发货地址上海市奉贤区 建议售价￥电询/瓶 更新日期2024年11月29日 产品规格48T/96T 即时洽谈立即询价查看联系方式 收藏产品发送留言
英文名称: T-cell Leukemia/Lymphoma 1A Human Recombinant 总访问: 298 国产/进口: 进口 半年访问: 16 产地/品牌: prospec 产品类别: 细胞生物学试剂 规格: PRO-726 最后更新: 2024-3-8 货号: CAS 号: 参考报价: 询价 立即询价 电话咨询
4a,c). Moreover, T1 and T3 cells were activated only by HLA-A2 and TdT double-positive patient leukemia cells. HLA-A2neg TdTpos malignancies failed to activate T1 and T3 cells, even in the presence of exogenously loaded peptide, while TdTneg HLA-A2pos primary follicular lymphoma and T-...
Cogent data on allogeneic haematopoietic stem-cell transplantation efficacy in advanced cutaneous T-cell lymphoma. Lancet. 2023 Jun 10;401(10392):1906-1907. doi: 10.1016/S0140-6736(23)00631-1. Epub 2023 Apr 24. PMID: 37105211. [21] Schett G, Mackensen A, Mougiakakos D. CAR T-cell ...